ライフサイエンスコーパス: mock

1 LY, PPSV23, a mixture of PPSV23/PLY, or PBS (mock).

2 dly with the random fiber arrangement of ECM-mock.

3 xpression cells, HEK293-hOATP2B1 than HEK293-MOCK.

4 9 vs. 1.77 +/- 0.34; state 3, 1.00 +/- 0.29; Mock: 1.60 +/- 0.53; complex 2-3-4: 1.00 +/- 0.30 vs. 1.

5 SV23 = 9.19, PPSV23/PLY = 10.45, PLY = 8.71, Mock = 16.83; P = 0.0467).

6 iple pressures between 8 and 45 mm Hg, using mock AH +/-100 muM L-NAME.

7 Additional eyes (n = 3) were perfused with mock AH containing fluorescent tracer microspheres to co

8 0 decreased cell proliferation compared with mock and pSV (scrambled vector) treatments, as determine

9 We tested it on both mock and real metagenomic data and benchmarked the perfo

10 produced protein amounts were equivalent in mock and Ric-8A-immunodepleted rabbit reticulocyte lysat

11 After intravaginal HSV-2 challenge, the mock and UL19/UL47 adenovirus groups developed severe ac

12 pplication of MyTaxa on in silico generated (mock) and real metagenomes of varied read length (100-20

13 roinflammatory chemokines CCL2 and CCL5 than mock- and E3 null virus-infected cells.

14 Comparing mock- and SAR-induced phloem exudate proteomes, 16 prote

15 no change in PD-L1 transcript levels between mock- and VZV-infected cells, indicating a posttranscrip

16 otype-specific rabbit polyclonal antisera or mock antisera were passively administered to rabbits bef

17 tforms for two primer pairs in a low density mock bacterial community.

18 ole (monatin plus monatin lactone/lactam) in mock beverage solutions, with an accompanying decrease i

19 andard clinical methods were as follows: for mock BT DNA, 98.5% sensitivity (95% confidence interval

20 Using a mock cataract surgery model, we discovered a unique subp

21 Mock cataract surgery provides a unique ex vivo model fo

22 n was greater in these myotubes than that in mock cells (Mock vs. Mb-Flag::GFP: state 4, 1.00 +/- 0.0

23 nd bleomycin-induced apoptosis compared with mock cells (p < 0.01).

24 on suppressed the in vitro invasion of Panc1/mock cells without effect on Panc1/syk cells.

25 he injection of CD40L transfectants, but not mock cells, resulted in VEGF expression and mediated a m

26 in activities of secreted MMP2 and MMP9 from mock cells.

27 cellular calcium concentration compared with mock cells.

28 formed significantly more colonies than the mock cells.

29 hile four negative-control animals underwent mock challenge.

30 introduction of a pediatric simulation-based mock code program.

31 proximately 4-10-fold) were stronger than in mock communities ( approximately 2-fold).

32 We evaluated marine samples and mock communities (containing 11 or 27 marine 16S clones)

33 Mock communities amplified with 515F-Y/926R yielded clos

34 hm performance was evaluated using simulated mock communities and fecal samples with spike-in pathoge

35 t beyond in silico predictions, testing with mock communities and field samples is important in prime

36 DNA was obtained from two low density mock communities of 11 diverse bacterial strains (with a

37 of 25 environmental samples and three known "mock communities" at a depth averaging 3.1 million reads

38 In several mock communities, DADA2 identified more real variants an

39 ls of closely and distantly related nematode mock communities, of known intragenomic identity and ric

40 MTTTRAGTTT) yield more accurate estimates of mock community abundances, produce longer amplicons that

41 sequencing library preparations using a DNA mock community and a cell control of known concentration

42 Shotgun metagenomic sequences of our mock community appear to be devoid of 16S chimeras, supp

43 Comparison of the diversity indices for the mock community data for the two primer pairs demonstrate

44 been designed that can reduce error rates in mock community data, but they change the sequence data i

45 When used to analyze a mock community dataset, FlowClus produced a lower error

46 Using a human-gut mock community dataset, we demonstrate that these method

47 We also develop a novel oral-specific mock community for pipeline validation.

48 The GSMs were first evaluated against mock community metagenomes, recently sequenced genomes a

49 ed and which was further benchmarked using a mock community of known composition.

50 Using mock community standards, we analyzed the amplification

51 sequences derived from the Human Microbiome Mock Community test sets and compared MetAmp and other t

52 f 14%, and the false discovery rate during a mock comparison was evaluated.

53 transiently transfected cells with pEGFP-N1 (mock control) as well as myocilin and optineurin plasmid

54 All mock controls developed recurrent lesions through day 10

55 ed similar functional characteristics as the mock controls, but they had an impaired ability to pass

56 n in recurrent lesion days compared with the mock controls, had the highest reduction in days with re

57 Laboratory-based mock crime studies have often been interpreted to mean t

58 o the right frontal cortex and perfused with mock CSF with 3% Dextran 500 at a flow rate of 1.0 muL/m

59 ex 50-species 210-genome 96-sample synthetic mock data set and then applied it to the Tara Oceans mic

60 was tested and validated on 20 synthetic and mock datasets ranging in community composition and compl

61 ing infection, in contrast to virus-infected mock-depleted mice that showed no clinical signs.

62 , Galphaq, Galpha13, and Galphas produced in mock-depleted RRL had characteristic resistance to limit

63 had been rapidly desensitized with 2.4G2 or mock-desensitized in mice in which monocyte/macrophages,

64 in the mock-immunized control group (pVAX-FI-Mock) developed primary lesions.

65 ethylation sensitive restriction enzymes and mock digested are then transformed to the likelihood of

66 thylhexyl-tetrabromo-benzoate (EH-TBB)) in a mock-digestive fluid matrix.

67 including inpatients from 7 units during 196 mock disaster days distributed across the 1-year period

68 tients were assigned to receive placebo with mock dose adjustment.

69 assayed by a range of concentrations of four mock drug compounds without harvesting and purification.

70 istance to Ksm and Spc was never observed in mock electroporated bacteria (frequency <6.2 x 10(-9)).

71 e and human mitochondrial and genomic DNA in mock forensic samples.

72 ines are produced following insect damage or mock herbivory (clipping).

73 m) together with either formalin-inactivated mock HSV-2 (FI-Mock) or with FI-HSV2.

74 strengths (1.5, 3.0, and 7.0 T), including a mock imager with no magnetic field as a control conditio

75 cantly lowered clinical severity compared to mock immunization (PPSV23 = 9.19, PPSV23/PLY = 10.45, PL

76 y lower than scores of the rabbits that were mock immunized with PBS and Freund's adjuvant or with PP

77 nated with baculovirus-expressed gK or gD or mock immunized.

78 Guinea pigs were either (i) mock immunized; (ii) immunized with gC2/gD2, with CpG an

79 lesions showed striking differences between mock-immunized and nHgbAI-immunized animals challenged w

80 d from Pneumocystis pneumonia, compared with mock-immunized animals (P= .047), following immunosuppre

81 shedding of HSV-2 DNA compared with that for mock-immunized animals.

82 , in the TG of ocularly challenged mice, and mock-immunized CD8alpha(-/-) mice had lower levels of PD

83 L30, and gD2t DNAs and all 10 animals in the mock-immunized control group (pVAX-FI-Mock) developed pr

84 the median peak and set point viral loads in mock-immunized controls (P < 0.01).

85 n of challenge HSV-1 and HSV-2 compared with mock-immunized controls, and were completely protected f

86 SV-1-specific neutralization antibodies than mock-immunized controls.

87 animals was significantly lower than that in mock-immunized controls.

88 A third group of mock-immunized cows serve as challenge controls.

89 gK-immunized group than in both the gD- and mock-immunized groups.

90 After challenge with wild-type HSV-1, all 10 mock-immunized guinea pigs developed multiple skin lesio

91 e following wild-type virus challenge, while mock-immunized hamsters displayed decreased activity.

92 Mock-immunized pigs were not protected from a challenge

93 r infection with WU2, when compared with the mock-immunized rabbits (P </= 0.007).

94 es in clinical scores compared with those in mock-immunized rabbits (P = 1.00) at 24 and 48 hours aft

95 r levels of PD-1 expression and latency than mock-immunized WT or CD8beta(-/-) mice.

96 l RNA was isolated from IL-1beta-induced and mock-induced control cells.

97 pe, cultured primary rat AMs and LMVECs were mock infected or infected with SEOV and analyzed for vir

98 y infected with either WT or M virus or were mock infected.

99 cells were cocultured with SEOV-infected or mock-infected AMs or LMVECs and analyzed for helper T ce

100 Although the lipid composition of mock-infected and virus-infected fibroblasts was similar

101 trometry to quantify glycerophospholipids in mock-infected and virus-infected fibroblasts, as well as

102 s infected with M. gallisepticum Rlow and 20 mock-infected animals at days 1, 3, 5, and 7 postinocula

103 ng peak expression of >100-fold over that in mock-infected animals.

104 cells compared to the ability of medium from mock-infected BCBl-1 cells.

105 gen consumption rates and mROS expression in mock-infected bone marrow-derived macrophages but reduce

106 msters following extranasal inoculation with mock-infected brain homogenate, different strains of pri

107 (ligands and receptors) in TMEV-infected and mock-infected C57BL/6 mice both with and without seizure

108 cells were significantly lower than those in mock-infected cells after IFN-alpha treatment.

109 ur results show that amino acid depletion in mock-infected cells caused loss of mTORC1 activity and l

110 HLA-DR and CD40 in human B cells compared to mock-infected cells or cells treated with an inactivated

111 ecipitation assays of virus-infected but not mock-infected cells revealed a signaling complex includi

112 The transfected DNA from mock-infected cells yielded proteins associated with rep

113 Relative to mock-infected cells, 168 signature proteins exhibited ab

114 RNA levels to between 20 and 30% of those in mock-infected cells, indicative of a normal Vhs activity

115 ly increased glucose consumption compared to mock-infected cells, suggesting a possible alteration in

116 12 (IL-12) in HCMV-infected cells but not in mock-infected cells.

117 L-28A, MCP-2, and IFN-alpha as compared with mock-infected cells.

118 tistically significant increases relative to mock-infected cells.

119 with proteinase K and samples prepared from mock-infected cells.

120 terferon-alpha production than the levels in mock-infected cells.

121 in infected cells but inhibited activity in mock-infected cells.

122 expression profiles of MNV-1-infected versus mock-infected cells.

123 cted with purified WT, inactivated virus, or mock-infected cells.

124 ls and adjacent uninfected cells compared to mock-infected cells.

125 nt and remained lower than those measured in mock-infected cells.

126 higher levels of MMP2 and MMP9 activity than mock-infected cells.

127 s lipid accumulation compared to that in the mock-infected control.

128 V-infected hepatocytes compared to that in a mock-infected control.

129 SC of reovirus-infected animals compared to mock-infected controls.

130 ined elevated at 28 dpi compared to those of mock-infected controls.

131 ls in G(2)/M phase was observed, compared to mock-infected controls.

132 ompared with uninfected "bystander" cells or mock-infected controls.

133 Infected and mock-infected corneas were compared at 1 day post inocul

134 When mock-infected endothelial cells were implanted alone in

135 PD-L1 expression in VZV-infected compared to mock-infected human brain vascular adventitial fibroblas

136 intracranial tumor xenografts, compared with mock-infected human GSCs.

137 Infected or mock-infected inoculum was identified within lymphatic v

138 TLR4 ligand (LPS) stimulation compared with mock-infected LPS-stimulated macrophages during a 6-d in

139 d TLR4 and TLR5, which declined over time in mock-infected macrophages, and enhanced both the intrace

140 nd compared their blood immune signatures to mock-infected mice before and after vaccination against

141 Mock-infected mice treated with phage showed no signific

142 In mock-infected mice, by contrast, >95% of inocula up to 5

143 symptomatic JEV-infected mice, but not from mock-infected mice, induced significant permeability of

144 brains, measured by gelatin zymography, than mock-infected mice.

145 ill exhibited extended processes, similar to mock-infected neurons.

146 ate times is similar to that taking place in mock-infected or in DeltaVHS RNase mutant-virus-infected

147 sal and bronchial brushes, respectively, and mock-infected or infected with RSV BT2a.

148 In contrast, only 3% of mock-infected or mice infected at 4 weeks developed tumo

149 We used mock-infected tissue as negative controls for ex-vivo ex

150 evels at 1, 3, and 7 days p.i. for infected, mock-infected, and normal corneas.

151 lionic neurons of latently infected, but not mock-infected, calves.

152 -sugar metabolites in HCMV-infected, but not mock-infected, cells.

153 lung MIP-2 or TNF-alpha levels compared with mock-infected/mock-treated mice.

154 y decreased 24 h postinfection compared with mock infection and thapsigargin treatment.

155 ing RNAs (siRNAs) 48 h prior to infection or mock infection in the presence of actinomycin D.

156 e cell types caused higher MMP activity than mock infection, suggesting that they may contribute to t

157 d MMP activity levels equivalent to those in mock infection.

158 tocytes in the four species and, compared to mock-injected controls, improved the pathology in the ca

159 he mosquito midgut by over 70% compared with mock-injected mosquitoes.

160 abolites extracted from roots and root hairs mock inoculated or inoculated with B. japonicum were ana

161 a 32% increase in trunk diameter compared to mock-inoculated control poplar trees.

162 omplish this, phloem exudates collected from mock-inoculated or SAR-induced leaves of wild-type Colum

163 lated with PC21A, 88% and 100% TC-PC177- and mock-inoculated piglets had diarrhea following challenge

164 tome analysis of B. japonicum-inoculated and mock-inoculated soybean root hairs using three different

165 m, and after 2 wk, plants were inoculated or mock-inoculated with a phloem-restricted virus.

166 adhesion in mice after injection with either mock inoculum or murine CMV (mCMV).

167 sting that the MMP2 axis might mediate Panc1/mock invasion.

168 n exposed to a social-evaluative stressor (a mock job interview).

169 ced levels of Mcl-1 expression dissipated to mock levels by 72 h postinfection.

170 eiterative Recombination can construct large mock libraries of at least 10(4) biosynthetic pathways.

171 We validated our platform by first screening mock libraries of epidermal growth factor (EGF) for stim

172 A mock manufacture was setup, and the impurities were intr

173 In a mock mixture of peptides, UVPD was used to screen for th

174 In a mock mixture of unmodified peptides and IRCX-cross-linke

175 A "mock modular form" is the holomorphic part of a harmonic

176 our definition of an algebraic "regularized mock modular form." As an application, we consider the m

177 for relating the coefficients of shadows and mock modular forms is not known.

178 ed endothelium-dependent vasodilation versus mock-ND at 9 and 12 weeks and endothelium-independent ar

179 response of human islets of Langerhans upon mock or CVB3 infection.

180 sed tumor size in pM treatment compared with mock or pSV treatments.

181 pe-RV-infected mice that had received either mock or TriGAS PET treatment revealed that many of the h

182 control Mut3 mice perinatally infected with mock or with a different neurotropic virus.

183 3 and IL-17, respectively, or scrambled miR (mock) or inhibitors confirmed that these miRs specifical

184 h either formalin-inactivated mock HSV-2 (FI-Mock) or with FI-HSV2.

185 erse aortic constriction, when compared with mock- or dominant-negative CCN1-infected control subject

186 irus had elevated levels of CCL2 compared to mock- or E3 null virus-infected cells.

187 (EC(50)) for DHG inhibition was identical in mock- or HCII-depleted plasma, suggesting a serpin-indep

188 e performed a rapid-response exercise to the mock outbreak scenario using whole-genome sequencing, ge

189 s with the taste control claim, although all mock packages were identical nutritionally.

190 Mock page cases (n = 16) were administered to 213 senior

191 Mock page cases (n = 16) were administered to 213 senior

192 pose of this study is to assess standardized mock page cases as a valid construct to assess clinical

193 pose of this study is to assess standardized mock page cases as a valid construct to assess clinical

194 A Mock Page program has been developed and adopted into a

195 A Mock Page program has been developed and adopted into a

196 Simulated mock pages demonstrate an innovative technique for train

197 Simulated mock pages demonstrate an innovative technique for train

198 n the presence of either a negative control "mock" peptide or a competitor fusion peptide (cFos-FosB-

199 as dramatically enhanced compared to that in mock-pretreated plants.

200 to transendocardial MPC injections (n=15) or mock procedures (n=5).

201 fibroblast-free ECMs, ECM-Sdc1, but not ECM-mock, promoted their attachment, invasion, and direction

202 ing strategy to build a population-tailored "Mock Reference" from the same GBS data used for downstre

203 ured the leakage voltage and current through mock rescuers while they were compressing the chests of

204 mammary fibroblasts (termed ECM-Sdc1 and ECM-mock, respectively).

205 ) was directly correlated to the outcome of "mock" reverse transcription-quantitative polymerase chai

206 It was also functional in mock selection experiments.

207 lidated the capabilities of this system in a mock selection for the enrichment of a His-tagged DNA-sc

208 hment efficiencies of >7000 were observed in mock selections of model libraries containing functional

209 an be obtained with the ADE microdevice from mock sexual assault samples in 14 min.

210 apsular infusion of Snx5-specific siRNA (vs. mock siRNA) decreases sodium excretion (Delta=-0.2+/-0.0

211 e, and delays receptor recycling compared to mock siRNA-transfected controls.

212 ctions of 200mug/g body weight of L-DOPS, or mock solution.

213 acy and control of instrument positioning in mock surgical trials involving 17 ophthalmic surgeons.

214 tute of Standards and Technology (NIST) with mock syringe blanks used in the construction of a commer

215 The results allow the (68)Ge activity of the mock syringe source to be expressed in terms of equivale

216 ive response ratios for a (68)Ge solid epoxy mock syringe source used in activity calibrators as a lo

217 study enabled NIST to calibrate epoxy-based mock syringe sources with a relative combined standard u

218 ously published methodology, solution-filled mock syringe sources, identical in geometry to the solid

219 e by -3.7%, allowing users of the commercial mock syringe surrogate source to calibrate their activit

220 lity for NIST to calibrate these epoxy-based mock syringes enabled, for the first time to our knowled

221 several NIST-constructed epoxy-based (68)Ge mock syringes were then used as artifact standards to de

222 The protocol involved a mock theft scenario that was previously used in a functi

223 letter, Ramanujan "defined" the notion of a mock theta function and offered some examples of functio

224 s paper shows that Ramanujan's definition of mock theta function is not equivalent to the modern defi

225 prising fact that the reduction of a certain mock theta function modulo l, for every l>/=5, is an eig

226 letter, Ramanujan introduced the notion of a mock theta function, and he offered some alleged example

227 This has led to an alternate definition of a mock theta function.

228 ablished for the first time that Ramanujan's mock theta functions actually satisfy his own definition

229 r Fourier series coefficients of Ramanujan's mock theta functions.

230 tisfies an identity analogous to Ramanujan's mock theta identities.

231 123 and 135 mum, respectively, and parental, mock-transduced (negative controls) and tumors expressin

232 antly greater inhibition compared to that in mock-transduced and parental cells.

233 hich became consistently more cytotoxic than mock-transduced cells against leukemia and solid tumor c

234 blood cells exhibited sickling compared with mock-transduced cells from sickle donors.

235 When compared with aged mock-transduced MSCs, aged MSCs overexpressing TERT, MYO

236 ing TERT and MYOCD were more clonogenic than mock-transduced MSCs.

237 Compared with mock transfectants, the HS6ST1 transfectants showed sign

238 SB's were significantly lower as compared to mock transfected cells.

239 positive C6 cells also grew more slowly than mock-transfected C6 cells in anchorage-dependent and anc

240 tenuated activation of ERK 1/2 compared with mock-transfected C6 cells, whereas focal adhesion kinase

241 e same treatment inhibited cell migration of mock-transfected C6 cells.

242 bly transfected with CD36 when compared with mock-transfected cells.

243 xtracellular matrix components compared with mock-transfected cells.

244 and spheroid formation compared to parental mock-transfected control.

245 alein, and PD146176) vs. vehicle-treated and mock-transfected controls.

246 r than tumors emerging from injection of the mock-transfected HNK-1-negative C6 cells.

247 ors in contrast to robust tumor formation by mock-transfected LNCaP cells.

248 obust tumor formation and metastasis seen in mock-transfected PC3 cells.

249 ted and untreated cells, transfected or not (mock-transfected) with alpha4beta2 nAChRs.

250 ter i.n. F. tularensis challenge relative to mock treated animals.

251 evated FAK phosphorylation compared with the mock treated control.

252 f immune responses in the two vaccinated and mock treated groups, similar quantities of viral RNA wer

253 re detected on average, 4 days later than in mock treated plants.

254 nsfected biotinylated plasmid recovered from mock-treated and infected cells were identified using ma

255 Controls were mock-treated and killed after 24 h.

256 (p = 0.0178) at 6 months of age compared to mock-treated animals.

257 /(perimeter)(2)] from 0.47 +/- 0.06 units in mock-treated cells to 0.09 +/- 0.03 units in S6K-overexp

258 or p21(WAF1/CIP1) was increased over that in mock-treated cells, and this, again, was predicted to re

259 Compared with mock-treated cells, rapamycin-pretreated human ECs (rapa

260 or abrin cytotoxicity compared with control mock-treated cells.

261 ulated in IFN-treated IHH from the level for mock-treated cells.

262 approximately fourfold less abundant than in mock-treated cells.

263 Compared to mock-treated controls, mo-br mice that received intraper

264 al replication and dissemination compared to mock-treated controls.

265 he lungs of mice receiving sCD14 compared to mock-treated controls.

266 Unlike mock-treated DCs, DCs primed with the gamma(1)34.5 null

267 of infection, whereas the majority (7/10) of mock-treated HEV-infected pigs cleared fecal viral shedd

268 ter liver damage and mortality compared with mock-treated IL-4Ralpha(-/-) mice.

269 -fold-higher numbers than after infection of mock-treated macrophages, making it unlikely that reduce

270 that many of the host genes activated in the mock-treated mice represent type I interferon (IFN) resp

271 educed IFN-gamma levels compared to those of mock-treated mice, suggesting that reductions in IFN-gam

272 gamma and IL-2 levels in serum compared with mock-treated mice.

273 ce treated with TriGAS than in the brains of mock-treated mice.

274 TNF-alpha levels compared with mock-infected/mock-treated mice.

275 ingle ratio relating phosphatase-treated and mock-treated samples.

276 Data from GAA- and mock-treated specimens generated by Aptima HPV were comp

277 e of Aptima HPV results from GAA-treated and mock-treated specimens was noted.

278 lloxan to destroy pancreatic islet cells, or mock-treated with vehicle, and maintained for 10 days be

279 ntravenously with 0.064-42 kBq of (211)At or mock-treated, and the kidneys, liver, lungs, and spleen

280 tment to remove EP-II-specific antibodies or mock treatment with a control peptide.

281 McCormick Place, Chicago, Ill, to witness a mock trial of a radiologist who had been accused of medi

282 users want even before you create the first mock-up of a system, the final product will provide a be

283 rified using either the test painting or the mock-up painting both measured with a table-top micro-XR

284 eta4) and vector-only-transfected cells (MDA/mock) using Affymetrix GeneChip analysis.

285 We vaccinated and mock vaccinated donor macaques and then harvested betwee

286 Unprotected animals that were mock vaccinated or received empty vector developed inter

287 Thirty-nine of these macaques were mock vaccinated, 43 were vaccinated with either DNA-SIV/

288 etween vaccinated animal cell recipients and mock-vaccinated animal cell recipients did not reach sig

289 ly higher in comparison to those in VC2- and mock-vaccinated animals (P < 0.01 or P < 0.001).

290 nger time after HCV challenge, than those of mock-vaccinated chimpanzees.

291 mals that received cells from vaccinated and mock-vaccinated donor animals.

292 ed time to death compared to results for the mock-vaccinated group.

293 iated with Tim-3 were the same among gK- and mock-vaccinated groups but higher than levels in the gD-

294 challenge, but the severity was greater for mock-vaccinated rabbits.

295 chimpanzees vaccinated using DNA/adenovirus, mock-vaccinated, and chimpanzees that had spontaneously

296 ived mast cells (BMMCs) survived longer than mock vector control BMMCs in cytokine-deprived condition

297 greater migration of F/P-expressing MCs than mock vector-transduced MCs.

298 r in these myotubes than that in mock cells (Mock vs. Mb-Flag::GFP: state 4, 1.00 +/- 0.09 vs. 1.77 +

299 and directly in the defined model matrix of mock wound fluid is demonstrated.

300 on is achieved in less than 1h straight from mock wound fluid without any extensive sample preparatio